CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 315 enrolled
Drug / intervention
nicotine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00790569
NCT00790569N/ACompleted
CompareCT.gov

Varenicline Versus Nicotine Replacement for Methadone-Maintained Smokers

Butler Hospital·interventional·Posted Nov 13, 2008·Updated Jun 6, 2018

In Brief

A clinical study evaluating nicotine, varenicline, and 1 other intervention for Bladder Cancer and 10 related conditions. Completed, enrolled 315 participants across 1 site.

Detailed Summary

RATIONALE: Varenicline, the nicotine patch, and nicotine gum help people stop smoking. It is not yet known whether varenicline is more effective than the nicotine patch given together with nicotine gum in helping smokers quit smoking. PURPOSE: This randomized clinical trial is studying varenicline to see how well it works compared with the nicotine patch given together with nicotine gum in helping smokers in a methadone treatment program stop smoking.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBladder Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Leukemia, Liver Cancer, Lung Cancer, Pancreatic Cancer, Tobacco Use Disorder
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 13, 2008
Enrollment StartSep 1, 2008
Primary CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 17.6 years ago

Interventions

nicotinedrug

Given transdermally and orally

vareniclinedrug

Given orally

placeboother

Given orally